Announcement of New Shares through Third-Party Allotment

Feb 21, 2018

Jiksak Bioengineering, Inc. secures 170 Million JPY from ANRI, OHARA Pharmaceutical Co.,Ltd, Essential Pharma Co., Ltd. and MediFuture Co., Ltd. to commercialize Nerve Organoid technology and develop a regenerative medical product.